We are live on ! Find out more

Cibus

CBUS

Market cap $126M

1.65 USD

-0.02

1.2%

At close Updated Aug 28, 4:00 PM EDT

1 day

-1.2%

5 days

-2.37%

1 month

-14.95%

3 months

13.79%

6 months

-55.53%

Year to date

-12.23%

1 year

21.32%

5 years

-99.16%

10 years

-99.71%

About: Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Employees: 118

Healthcare Biotechnology

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 14.3%

Neutral 71.4%

Negative 14.3%

Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript

Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript

Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates

Cibus (CBUS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.61 per share a year ago.

Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates

Cibus Q2 Earnings Call Highlights

Cibus NASDAQ: CBUS reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients program and updated the expected timing of its initial rice launch in Latin America.

Cibus Q2 Earnings Call Highlights

Cibus Reports Second Quarter Financial Results and Provides Business Update

Commercialization execution advances in Rice and Sustainable Ingredients United States and European Union now aligned on generally treating crops with no added foreign DNA as conventionally bred Quarterly net cash usage declined 19% sequentially and 31% year over year SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today announced its financial results for the quarter ended June 30, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m.

Cibus Reports Second Quarter Financial Results and Provides Business Update

Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call

SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a technology company that helps farmers grow more food with fewer inputs, today announced that the company will report second quarter 2026 financial results on Thursday, August 13, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call

Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus

Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years

Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus

Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced key leadership changes pursuant to the Company's previously announced succession planning strategy. As part of this plan, Craig Wichner, a board member since November 2025, has been appointed as the Company's Chief Executive Officer. Peter Beetham, who has served as the Company's Interim Chief Executive Officer, will continue his role as the Company's President and Chief Operating Officer. Concurrently, both Mr. Wichner and Dr. Beetham resigned from the Cibus Board of Directors as part of this reorganization and plan.

Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation

Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript

Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript

Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript

Zacks Investment Research

Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates

Cibus (CBUS) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.74 per share a year ago.

Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates

Cibus Q1 Earnings Call Highlights

Cibus NASDAQ: CBUS reported first-quarter 2026 results and said it is advancing toward commercialization across its rice and sustainable ingredients programs, while also reducing expenses and extending its cash runway into late in the first quarter of 2027.

Cibus Q1 Earnings Call Highlights

See News Rankings

Price charts implemented using Lightweight Charts™